Cover Image
市場調查報告書

全球中央靜脈導管市場:醫療設備的開發平台評估

Central Venous Catheters - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 229188
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
全球中央靜脈導管市場:醫療設備的開發平台評估 Central Venous Catheters - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年05月05日 內容資訊: 英文 71 Pages
簡介

本報告提供全球中央靜脈導管市場上的主要開發中產品 (醫療設備) 及其臨床實驗進展之相關調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 中央靜脈導管市場概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:法規各途徑
  • 開發中產品:估計認證各時期
  • 開發中產品:現在進行中的臨床實驗

第4章 中央靜脈導管:臨床實驗中的開發中產品 (各企業)

  • 中央靜脈導管的企業:各臨床實驗階段的開發中產品
  • 中央靜脈導管:各臨床實驗階段的開發中產品

第5章 中央靜脈導管:企業·產品概要

  • Ash Access Technology, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Bluegrass Vascular Technologies, Inc.
  • Charite - Universitatsmedizin Berlin
  • Globe Medical Tech, Inc.
  • i360medical Limited
  • Infusense Corp
  • Marvao Medical Devices Limited
  • Nipro
  • Pavmed Inc
  • S3V Vascular Technologies
  • Sharklet Technologies, Inc.
  • Teleflex Incorporated
  • The Johns Hopkins University
  • The University of Utah
  • Vascular Access Technologies, Inc.
  • Vindica Therapeutics, Inc

第6章 中央靜脈導管市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Central Venous Catheters - Medical Devices Pipeline Assessment, 2017" provides an overview of Central Venous Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Venous Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Central Venous Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Central Venous Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Central Venous Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Central Venous Catheters Overview 6

3 Products under Development 7

  • 3.1 Central Venous Catheters - Pipeline Products by Stage of Development 7
  • 3.2 Central Venous Catheters - Pipeline Products by Segment 8
  • 3.3 Central Venous Catheters - Pipeline Products by Territory 9
  • 3.4 Central Venous Catheters - Pipeline Products by Regulatory Path 10
  • 3.5 Central Venous Catheters - Pipeline Products by Estimated Approval Date 11
  • 3.6 Central Venous Catheters - Ongoing Clinical Trials 12

4 Central Venous Catheters - Pipeline Products under Development by Companies 13

  • 4.1 Central Venous Catheters Companies - Pipeline Products by Stage of Development 13
  • 4.2 Central Venous Catheters - Pipeline Products by Stage of Development 14

5 Central Venous Catheters Companies and Product Overview 15

  • 5.1 Ash Access Technology Inc Company Overview 15
    • 5.1.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Bactiguard AB Company Overview 16
    • 5.2.1 Bactiguard AB Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 Bluegrass Vascular Technologies Inc Company Overview 17
    • 5.3.1 Bluegrass Vascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Charite - Universitatsmedizin Berlin Company Overview 19
    • 5.4.1 Charite - Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.5 Globe Medical Tech Inc Company Overview 20
    • 5.5.1 Globe Medical Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.6 i360medical Limited Company Overview 21
    • 5.6.1 i360medical Limited Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.7 Infusense Corp Company Overview 22
    • 5.7.1 Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.8 Marvao Medical Devices Limited Company Overview 23
    • 5.8.1 Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.9 Nipro Corp Company Overview 24
    • 5.9.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.10 Pavmed Inc Company Overview 25
    • 5.10.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.11 S3V Vascular Technologies Company Overview 26
    • 5.11.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.12 Sharklet Technologies, Inc. Company Overview 27
    • 5.12.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.13 Silver Bullet Therapeutics, Inc. Company Overview 28
    • 5.13.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.14 Teleflex Inc Company Overview 29
    • 5.14.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.15 The University of Utah Company Overview 30
    • 5.15.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.16 University of Illinois at Chicago Company Overview 31
    • 5.16.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.17 Vascular Access Technologies, Inc. Company Overview 32
    • 5.17.1 Vascular Access Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.18 Vindica Therapeutics, Inc Company Overview 33
    • 5.18.1 Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview 33

6 Central Venous Catheters- Recent Developments 34

  • 6.1 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 34
  • 6.2 Apr 24, 2017: First Patients Enrolled In Bluegrass Vascular Post-Market SAVE Study 36
  • 6.3 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 36
  • 6.4 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 37
  • 6.5 Apr 03, 2017: Retractable Technologies Reports Results for the Year 2016 37
  • 6.6 Mar 31, 2017: B. Braun continues its sales and earnings growth 38
  • 6.7 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 40
  • 6.8 Mar 21, 2017: PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer 41
  • 6.9 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 42
  • 6.10 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 42
  • 6.11 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 42
  • 6.12 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 43
  • 6.13 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 44
  • 6.14 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 44
  • 6.15 Feb 22, 2017: Change in the B. Braun Management Board 46
  • 6.16 Dec 09, 2016: Centurion Recalls Multi-Med Single Lumen Catheters due to Excess Material that May Split or Separate 46
  • 6.17 Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit's Opinion 47
  • 6.18 Nov 14, 2016: Retractable Technologies Reports Results as of September 30, 2016 47
  • 6.19 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 49
  • 6.20 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 50
  • 6.21 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 51
  • 6.22 Oct 10, 2016: Teleflex Receives FDA Clearance for ARROW JACC with Chlorag+ard Technology and Tunneler 54
  • 6.23 Sep 13, 2016: B. Braun To Showcase Introcan Safety IV Catheter at AVA 54
  • 6.24 Sep 13, 2016: B. Braun To Showcase Introcan Safety 3 Closed IV Catheter at AVA 55
  • 6.25 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 55
  • 6.26 Aug 30, 2016: Bluegrass Vascular Secures CE Mark Approval and Announces Successful Commercial Use of The Surfacer Inside-Out Access Catheter System 55
  • 6.27 Aug 16, 2016: PAVmed Announces Second Quarter 2016 Financial Results and Provides Business Update 56
  • 6.28 Aug 16, 2016: Retractable Technologies Reports Results as of June 30, 2016 57
  • 6.29 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 59
  • 6.30 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 59
  • 6.31 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 61
  • 6.32 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 63
  • 6.33 Jun 09, 2016: Patient and Healthcare Worker Safety Key Areas of Focus for B. Braun Medical at APIC 63
  • 6.34 Jun 03, 2016: LEPUCARE established in India 64
  • 6.35 May 17, 2016: Retractable Technologies Reports Results for the First Quarter of 2016 64
  • 6.36 May 13, 2016: PAVmed Announces First Quarter 2016 Financial Results 65
  • 6.37 May 13, 2016: B. Braun Focused on Helping Educate Nurses About USP and Improving Vascular Access at INS 2016 66
  • 6.38 May 10, 2016: ICU Medical Announces First Quarter 2016 Results 67

7 Appendix 68

  • 7.1 Methodology 68
  • 7.2 About GlobalData 71
  • 7.3 Contact Us 71
  • 7.4 Disclaimer 71

List of Tables

1.1 List of Tables

  • Table 1: Central Venous Catheters - Pipeline Products by Stage of Development 7
  • Table 2: Central Venous Catheters - Pipeline Products by Segment 8
  • Table 3: Central Venous Catheters - Pipeline Products by Territory 9
  • Table 4: Central Venous Catheters - Pipeline Products by Regulatory Path 10
  • Table 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date 11
  • Table 6: Central Venous Catheters - Ongoing Clinical Trials 12
  • Table 7: Central Venous Catheters Companies - Pipeline Products by Stage of Development 13
  • Table 8: Central Venous Catheters - Pipeline Products by Stage of Development 14
  • Table 9: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 10: BaxCath Impregnation System - Product Status 15
  • Table 11: BaxCath Impregnation System - Product Description 15
  • Table 12: Bactiguard AB Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 13: Transvascular Injection Catheter - Product Status 16
  • Table 14: Transvascular Injection Catheter - Product Description 16
  • Table 15: Bluegrass Vascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 16: Surfacer Inside-Out Access Catheter System - Product Status 17
  • Table 17: Surfacer Inside-Out Access Catheter System - Product Description 17
  • Table 18: Bluegrass Vascular Technologies Inc - Ongoing Clinical Trials Overview 18
  • Table 19: Surfacer Inside-Out Access Catheter System - Clinical Study of the Surfacer Inside-Out Access Catheter System 18
  • Table 20: Surfacer Inside-Out Access Catheter System - Surfacer System to Facilitate Access in Venous Occlusions 18
  • Table 21: Charite - Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 22: Central Venous Permanent Catheter - Product Status 19
  • Table 23: Central Venous Permanent Catheter - Product Description 19
  • Table 24: Globe Medical Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 25: Safety IV Catheter - Product Status 20
  • Table 26: Safety IV Catheter - Product Description 20
  • Table 27: i360medical Limited Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 28: Suture-Less Insertion And Stabilization Device - IV Catheter Lines - Product Status 21
  • Table 29: Suture-Less Insertion And Stabilization Device - IV Catheter Lines - Product Description 21
  • Table 30: Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 31: Infusense System - Product Status 22
  • Table 32: Infusense System - Product Description 22
  • Table 33: Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 34: NexSite 8Fr Single Lumen Central Venous Catheter - Product Status 23
  • Table 35: NexSite 8Fr Single Lumen Central Venous Catheter - Product Description 23
  • Table 36: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 37: Biocompatible Intravenous Catheter - Product Status 24
  • Table 38: Biocompatible Intravenous Catheter - Product Description 24
  • Table 39: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 40: NextCath - Product Status 25
  • Table 41: NextCath - Product Description 25
  • Table 42: S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 43: 3V AGILE - Product Status 26
  • Table 44: 3V AGILE - Product Description 26
  • Table 45: Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 46: Sharklet Central Venous Catheter - Product Status 27
  • Table 47: Sharklet Central Venous Catheter - Product Description 27
  • Table 48: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 49: Cathanic Venous Catheter - Product Status 28
  • Table 50: Cathanic Venous Catheter - Product Description 28
  • Table 51: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 52: ARROW JACC Nurse Insertion CVC System - Product Status 29
  • Table 53: ARROW JACC Nurse Insertion CVC System - Product Description 29
  • Table 54: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 55: WIN NIC Central Venous Catheter Introducer Kit - Product Status 30
  • Table 56: WIN NIC Central Venous Catheter Introducer Kit - Product Description 30
  • Table 57: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 58: Extendable Intravenous Catheter - Product Status 31
  • Table 59: Extendable Intravenous Catheter - Product Description 31
  • Table 60: Vascular Access Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 61: SAFECVAD - Product Status 32
  • Table 62: SAFECVAD - Product Description 32
  • Table 63: Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 64: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Status 33
  • Table 65: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Description 33
  • Table 66: Glossary 70

List of Figures

1.2 List of Figures

  • Figure 1: Central Venous Catheters - Pipeline Products by Stage of Development 7
  • Figure 2: Central Venous Catheters - Pipeline Products by Segment 8
  • Figure 3: Central Venous Catheters - Pipeline Products by Territory 9
  • Figure 4: Central Venous Catheters - Pipeline Products by Regulatory Path 10
  • Figure 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date 11
  • Figure 6: Central Venous Catheters - Ongoing Clinical Trials 12
Back to Top